The clinical trial will assess the safety and effectiveness of a pulmonary vein isolation-only strategy to treat patients with persistent atrial fibrillation using the company’s Arctic Front Advance ...

(RTTNews) - Medtronic plc (MDT) said Monday that it received U.S. Food and Drug Administration expanded approval for the Arctic Front Family of Cardiac Cryoablation Catheters for the treatment of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Medtronic announced it received expanded ...

Medtronic plc MDT recently announced the receipt of the FDA’s expanded approval for Freezor and Freezor Xtra Cardiac Cryoablation. This approval is likely to bolster Medtronic’s cardiac Ablation ...

DUBLIN, Nov. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clinical ...

A national study is shedding light on how to more effectively treat atrial fibrillation (AF) -- a common heart rhythm problem associated with increased risk of stroke and heart failure. The study ...

- First and Only Approval to Indicate Cryoablation as an Initial Rhythm Control Strategy - Offers Safe, Effective Alternative to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrythmia ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem ...

Cardiac mapper turned treatment of his own heart condition into a new career NORTHAMPTON, MA / ACCESS Newswire / / David ...

"Advanced ablation options for electrophysiology" was originally created and published by Medical Device Network, a GlobalData owned brand.